Alterola Biotech Stock Short Ratio
| ABTI Stock | USD 0 0.00 0.00% |
Alterola Biotech fundamentals help investors to digest information that contributes to Alterola Biotech's financial success or failures. It also enables traders to predict the movement of Alterola Pink Sheet. The fundamental analysis module provides a way to measure Alterola Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Alterola Biotech pink sheet.
Alterola |
Alterola Biotech Company Short Ratio Analysis
Alterola Biotech's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
Based on the latest financial disclosure, Alterola Biotech has a Short Ratio of 0.0 times. This is 100.0% lower than that of the Healthcare sector and about the same as Drug Manufacturers—Specialty & Generic (which currently averages 0.0) industry. The short ratio for all United States stocks is 100.0% higher than that of the company.
Alterola Short Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Alterola Biotech's direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Alterola Biotech could also be used in its relative valuation, which is a method of valuing Alterola Biotech by comparing valuation metrics of similar companies.Alterola Biotech is currently under evaluation in short ratio category among its peers.
Alterola Fundamentals
| Return On Equity | -1.27 | |||
| Return On Asset | -0.67 | |||
| Current Valuation | 68.08 M | |||
| Shares Outstanding | 807.05 M | |||
| Price To Book | 6.29 X | |||
| EBITDA | (6.47 M) | |||
| Net Income | (6.47 M) | |||
| Cash And Equivalents | 61.54 K | |||
| Total Debt | 251.18 K | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 0.10 X | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | 44.34 K | |||
| Earnings Per Share | (0.01) X | |||
| Beta | -6.65 | |||
| Market Capitalization | 39.55 M | |||
| Total Asset | 12.13 K | |||
| Net Asset | 12.13 K |
About Alterola Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Alterola Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alterola Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alterola Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Other Information on Investing in Alterola Pink Sheet
Alterola Biotech financial ratios help investors to determine whether Alterola Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Alterola with respect to the benefits of owning Alterola Biotech security.